ID   PRGR_MOUSE              Reviewed;         926 AA.
AC   Q00175; A6H6A5; E9QPW3;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   18-JAN-2017, sequence version 2.
DT   07-APR-2021, entry version 181.
DE   RecName: Full=Progesterone receptor;
DE            Short=PR;
DE   AltName: Full=Nuclear receptor subfamily 3 group C member 3;
GN   Name=Pgr; Synonyms=Nr3c3, Pr;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RX   PubMed=2069958; DOI=10.1021/bi00242a029;
RA   Schott D.R., Shyamala G., Schneider W., Parry G.;
RT   "Molecular cloning, sequence analyses, and expression of complementary DNA
RT   encoding murine progesterone receptor.";
RL   Biochemistry 30:7014-7020(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   TISSUE=Brain;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2014) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RC   STRAIN=129/Sv;
RX   PubMed=7802637; DOI=10.1006/bbrc.1994.2778;
RA   Hagihara K., Wu-Peng X.S., Funabashi T., Kato J., Pfaff D.W.;
RT   "Nucleic acid sequence and DNase hypersensitive sites of the 5' region of
RT   the mouse progesterone receptor gene.";
RL   Biochem. Biophys. Res. Commun. 205:1093-1101(1994).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=8603049; DOI=10.1016/0960-0760(95)00254-5;
RA   Lydon J.P., DeMayo F.J., Conneely O.M., O'Malley B.W.;
RT   "Reproductive phenotpes of the progesterone receptor null mutant mouse.";
RL   J. Steroid Biochem. Mol. Biol. 56:67-77(1996).
RN   [7]
RP   FUNCTION (ISOFORM B), AND DISRUPTION PHENOTYPE (ISOFORMS A AND B).
RX   PubMed=10976068; DOI=10.1126/science.289.5485.1751;
RA   Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., Conneely O.M.;
RT   "Subgroup of reproductive functions of progesterone mediated by
RT   progesterone receptor-B isoform.";
RL   Science 289:1751-1754(2000).
RN   [8]
RP   INTERACTION WITH KLF9.
RX   PubMed=12672823; DOI=10.1074/jbc.m212098200;
RA   Zhang X.L., Zhang D., Michel F.J., Blum J.L., Simmen F.A., Simmen R.C.;
RT   "Selective interactions of Kruppel-like factor 9/basic transcription
RT   element-binding protein with progesterone receptor isoforms A and B
RT   determine transcriptional activity of progesterone-responsive genes in
RT   endometrial epithelial cells.";
RL   J. Biol. Chem. 278:21474-21482(2003).
RN   [9]
RP   TISSUE SPECIFICITY (ISOFORMS A AND B).
RX   PubMed=15044369; DOI=10.1210/en.2004-0212;
RA   Gava N., Clarke C.L., Byth K., Arnett-Mansfield R.L., deFazio A.;
RT   "Expression of progesterone receptors A and B in the mouse ovary during the
RT   estrous cycle.";
RL   Endocrinology 145:3487-3494(2004).
RN   [10]
RP   TISSUE SPECIFICITY (ISOFORMS A AND B).
RX   PubMed=15878961; DOI=10.1210/en.2005-0346;
RA   Aupperlee M.D., Smith K.T., Kariagina A., Haslam S.Z.;
RT   "Progesterone receptor isoforms A and B: temporal and spatial differences
RT   in expression during murine mammary gland development.";
RL   Endocrinology 146:3577-3588(2005).
RN   [11]
RP   TISSUE SPECIFICITY (ISOFORMS A AND B).
RX   PubMed=17003284; DOI=10.1677/joe.1.06923;
RA   Turgeon J.L., Waring D.W.;
RT   "Differential expression and regulation of progesterone receptor isoforms
RT   in rat and mouse pituitary cells and LbetaT2 gonadotropes.";
RL   J. Endocrinol. 190:837-846(2006).
CC   -!- FUNCTION: The steroid hormones and their receptors are involved in the
CC       regulation of eukaryotic gene expression and affect cellular
CC       proliferation and differentiation in target tissues. Depending on the
CC       isoform, progesterone receptor functions as transcriptional activator
CC       or repressor. {ECO:0000250|UniProtKB:P06401}.
CC   -!- FUNCTION: [Isoform A]: Ligand-dependent transdominant repressor of
CC       steroid hormone receptor transcriptional activity including repression
CC       of its isoform B, MR and ER. Transrepressional activity may involve
CC       recruitment of corepressor NCOR2. {ECO:0000250|UniProtKB:P06401}.
CC   -!- FUNCTION: [Isoform B]: Transcriptional activator of several
CC       progesteron-dependent promoters in a variety of cell types. Involved in
CC       activation of SRC-dependent MAPK signaling on hormone stimulation.
CC       {ECO:0000250|UniProtKB:P06401}.
CC   -!- SUBUNIT: Interacts with SMARD1 and UNC45A. Interacts with CUEDC2; the
CC       interaction promotes ubiquitination, decreases sumoylation, and
CC       represses transcriptional activity. Interacts with PIAS3; the
CC       interaction promotes sumoylation of PR in a hormone-dependent manner,
CC       inhibits DNA-binding, and alters nuclear export. Interacts with SP1;
CC       the interaction requires ligand-induced phosphorylation on Ser-294 by
CC       ERK1/2 MAPK. Interacts with PRMT2 (By similarity). Isoform A interacts
CC       with NCOR2. Isoform B (but not isoform A) interacts with NCOA2 and
CC       NCOA1. Isoform B (but not isoform A) interacts with KLF9.
CC       {ECO:0000250|UniProtKB:P06401, ECO:0000269|PubMed:12672823}.
CC   -!- INTERACTION:
CC       Q00175; P19785: Esr1; NbExp=5; IntAct=EBI-346821, EBI-346765;
CC       Q00175; P42227: Stat3; NbExp=4; IntAct=EBI-346821, EBI-602878;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Nucleoplasmic shuttling
CC       is both hormone- and cell cycle-dependent. On hormone stimulation,
CC       retained in the cytoplasm in the G(1) and G(2)/M phases (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=B; Synonyms=PRB, PR-B;
CC         IsoId=Q00175-1; Sequence=Displayed;
CC       Name=A; Synonyms=PRA, PR-A;
CC         IsoId=Q00175-2; Sequence=VSP_058743;
CC   -!- TISSUE SPECIFICITY: Expression of isoform A and isoform B in mammary
CC       epithelial cells is temporally and spatially separated during normal
CC       mammary gland development. Isoform A and isoform B are expressed in the
CC       pituitary. Isoform A and isoform B are differentially expressed in the
CC       ovary and oviduct, and the level of expression is dependent on both the
CC       cell type and estrous cycle stage. {ECO:0000269|PubMed:15044369,
CC       ECO:0000269|PubMed:15878961, ECO:0000269|PubMed:17003284}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- PTM: Phosphorylated on multiple serine sites. Several of these sites
CC       are hormone-dependent. Phosphorylation on Ser-294 is highly hormone-
CC       dependent and modulates ubiquitination and sumoylation on Lys-388.
CC       Phosphorylation on Ser-345 also requires induction by hormone. Basal
CC       phosphorylation on Ser-82, Ser-163, Ser-191 and Ser-400 is increased in
CC       response to progesterone and can be phosphorylated in vitro by the
CC       CDK2-A1 complex. Increased levels of phosphorylation on Ser-400 also in
CC       the presence of EGF, heregulin, IGF, PMA and FBS. Phosphorylation at
CC       this site by CDK2 is ligand-independent, and increases nuclear
CC       translocation and transcriptional activity. Phosphorylation at Ser-163
CC       and Ser-294, but not at Ser-191, is impaired during the G(2)/M phase of
CC       the cell cycle. Phosphorylation on Ser-345 by ERK1/2 MAPK is required
CC       for interaction with SP1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Sumoylation is hormone-dependent and represses transcriptional
CC       activity. Sumoylation on all three sites is enhanced by PIAS3.
CC       Desumoylated by SENP1. Sumoylation on Lys-388, the main site of
CC       sumoylation, is repressed by ubiquitination on the same site, and
CC       modulated by phosphorylation at Ser-294 (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitination is hormone-dependent and represses sumoylation on
CC       the same site. Promoted by MAPK-mediated phosphorylation on Ser-294 (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required
CC       for plasma membrane targeting and for rapid intracellular signaling via
CC       ERK and AKT kinases and cAMP generation (By similarity). {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Infertile. Inability to ovulate, uterine
CC       hyperplasia and inflammation, severely limited mammary gland
CC       development and an impairment in the induction of a sexual behavioral
CC       response (PubMed:8603049). In isoform A-defective mice less oocytes are
CC       produced, only a subset of implantation-specific uterine epithelial
CC       target genes is regulated, and an increased progesterone-dependent
CC       proliferative activity of isoform B in the uterine epithelium is
CC       observed. Isoform B-defective mice showed unaffected ovulation
CC       (PubMed:10976068). {ECO:0000269|PubMed:10976068,
CC       ECO:0000269|PubMed:8603049}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA39971.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M68915; AAA39971.1; ALT_SEQ; mRNA.
DR   EMBL; AC113506; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC160964; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466522; EDL24960.1; -; Genomic_DNA.
DR   EMBL; BC145807; AAI45808.1; -; mRNA.
DR   EMBL; U12644; AAA66067.1; -; Genomic_DNA.
DR   CCDS; CCDS22816.1; -. [Q00175-1]
DR   PIR; A39596; A39596.
DR   RefSeq; NP_032855.2; NM_008829.2. [Q00175-1]
DR   SMR; Q00175; -.
DR   IntAct; Q00175; 5.
DR   STRING; 10090.ENSMUSP00000063562; -.
DR   ChEMBL; CHEMBL4969; -.
DR   iPTMnet; Q00175; -.
DR   PhosphoSitePlus; Q00175; -.
DR   jPOST; Q00175; -.
DR   PaxDb; Q00175; -.
DR   PRIDE; Q00175; -.
DR   ProteomicsDB; 291877; -. [Q00175-1]
DR   ProteomicsDB; 291878; -. [Q00175-2]
DR   Antibodypedia; 1685; 2935 antibodies.
DR   Ensembl; ENSMUST00000070463; ENSMUSP00000063562; ENSMUSG00000031870. [Q00175-1]
DR   Ensembl; ENSMUST00000098986; ENSMUSP00000096584; ENSMUSG00000031870. [Q00175-2]
DR   Ensembl; ENSMUST00000189181; ENSMUSP00000140124; ENSMUSG00000031870. [Q00175-1]
DR   GeneID; 18667; -.
DR   KEGG; mmu:18667; -.
DR   UCSC; uc009odo.1; mouse.
DR   CTD; 5241; -.
DR   MGI; MGI:97567; Pgr.
DR   eggNOG; KOG3575; Eukaryota.
DR   GeneTree; ENSGT00940000159713; -.
DR   InParanoid; Q00175; -.
DR   OMA; GSPHWPG; -.
DR   PhylomeDB; Q00175; -.
DR   TreeFam; TF106510; -.
DR   Reactome; R-MMU-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-MMU-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-MMU-4090294; SUMOylation of intracellular receptors.
DR   Reactome; R-MMU-9018519; Estrogen-dependent gene expression.
DR   BioGRID-ORCS; 18667; 1 hit in 52 CRISPR screens.
DR   PRO; PR:Q00175; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q00175; protein.
DR   Bgee; ENSMUSG00000031870; Expressed in uterus and 173 other tissues.
DR   GO; GO:0030424; C:axon; ISO:MGI.
DR   GO; GO:0043679; C:axon terminus; ISO:MGI.
DR   GO; GO:0000785; C:chromatin; IC:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0043197; C:dendritic spine; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; ISO:MGI.
DR   GO; GO:0043005; C:neuron projection; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0043204; C:perikaryon; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0051117; F:ATPase binding; ISO:MGI.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:MGI.
DR   GO; GO:0019899; F:enzyme binding; ISO:MGI.
DR   GO; GO:0042562; F:hormone binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0004879; F:nuclear receptor activity; IMP:MGI.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:MGI.
DR   GO; GO:0001225; F:RNA polymerase II transcription coactivator binding; ISO:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:MGI.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:MGI.
DR   GO; GO:0005496; F:steroid binding; ISO:MGI.
DR   GO; GO:0003707; F:steroid hormone receptor activity; IDA:MGI.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0002070; P:epithelial cell maturation; IMP:MGI.
DR   GO; GO:0060180; P:female mating behavior; ISO:MGI.
DR   GO; GO:0030518; P:intracellular steroid hormone receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0048286; P:lung alveolus development; IMP:MGI.
DR   GO; GO:0030879; P:mammary gland development; IMP:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:MGI.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:1904709; P:negative regulation of granulosa cell apoptotic process; ISO:MGI.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; IMP:MGI.
DR   GO; GO:0038001; P:paracrine signaling; IMP:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:MGI.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; ISO:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0050847; P:progesterone receptor signaling pathway; IDA:MGI.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; IMP:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:MGI.
DR   GO; GO:0042220; P:response to cocaine; ISO:MGI.
DR   GO; GO:0060748; P:tertiary branching involved in mammary gland duct morphogenesis; IMP:MGI.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR000128; Progest_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF02161; Prog_receptor; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00544; PROGESTRONER.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Cytoplasm; DNA-binding; Isopeptide bond;
KW   Lipid-binding; Lipoprotein; Metal-binding; Nucleus; Palmitate;
KW   Phosphoprotein; Receptor; Reference proteome; Steroid-binding;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..926
FT                   /note="Progesterone receptor"
FT                   /id="PRO_0000053695"
FT   DOMAIN          672..906
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        557..632
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         560..580
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         596..615
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..559
FT                   /note="Modulating, Pro-Rich"
FT   REGION          1..165
FT                   /note="AF3; mediates transcriptional activation (in isoform
FT                   B)"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   REGION          166..305
FT                   /note="Mediates transcriptional transrepression (in isoform
FT                   A)"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   REGION          453..539
FT                   /note="AF1; mediates transcriptional activation"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   REGION          673..926
FT                   /note="AF2; mediates transcriptional activation"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOTIF           56..60
FT                   /note="LXXL motif 1"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOTIF           116..120
FT                   /note="LXXL motif 1"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOTIF           184..188
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         163
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         191
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         294
FT                   /note="Phosphoserine; by MAPK1"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         345
FT                   /note="Phosphoserine; by MAPK"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         400
FT                   /note="Phosphoserine; by CDK2"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   MOD_RES         669
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        388
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        388
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06401"
FT   CROSSLNK        524
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..165
FT                   /note="Missing (in isoform A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_058743"
FT   CONFLICT        104
FT                   /note="A -> P (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        125
FT                   /note="T -> P (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        173..181
FT                   /note="AGDSSGTGA -> VGDQSGTGR (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        235
FT                   /note="A -> S (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        250
FT                   /note="S -> Q (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="A -> P (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        327
FT                   /note="D -> E (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        351..355
FT                   /note="PPVPC -> TPVPR (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        425
FT                   /note="R -> A (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        464
FT                   /note="Missing (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        483
FT                   /note="G -> A (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        497
FT                   /note="A -> G (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        663
FT                   /note="G -> S (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        692
FT                   /note="V -> I (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        859
FT                   /note="S -> T (in Ref. 1; AAA39971)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   926 AA;  98981 MW;  E26DDDE9529996A7 CRC64;
     MTELQAKDPQ VLHTSGASPS PPHIGSPLLA RLDSGPFQGS QHSDVSSVVS PIPISLDGLL
     FPRSCRGPEL PDGKTGDQQS LSDVEGAFSG VEATHREGGR NSRAPEKDSR LLDSVLDSLL
     TPSGTEQSHA SPPACEAITS WCLFGPELPE DPRSVPATKG LLSPLMSRPE IKAGDSSGTG
     AGQKVLPKGL SPPRQLLLPT SGSAHWPGAG VKPSPQPAAG EVEEDSGLET EGSAAPLLKS
     KPRALEGTGS GGGVAANAAS AAPGGVTLVP KEDSRFSAPR VSLEQDSPIA PGRSPLATTV
     VDFIHVPILP LNHALLAART RQLLEGDSYD GGATAQGPFA PPRGSPSAPS PPVPCGDFPD
     CTYPLEGDPK EDVFPLYGDF QTPGLKIKEE EEGADAAVRS PRPYLSAGAS SSTFPDFPLA
     PAPQRAPSSR PGEAAVAGGP SSAAVSPASS SGSALECILY KAEGAPPTQG SFAPLPCKPP
     AAGSCLLPRD SLPAAPATAA APAIYQPLGL NGLPQLGYQA AVLKDSLPQV YPPYLNYLRP
     DSEASQSPQY GFDSLPQKIC LICGDEASGC HYGVLTCGSC KVFFKRAMEG QHNYLCAGRN
     DCIVDKIRRK NCPACRLRKC CQAGMVLGGR KFKKFNKVRV MRTLDGVALP QSVGLPNESQ
     ALGQRITFSP NQEIQLVPPL INLLMSIEPD VVYAGHDNTK PDTSSSLLTS LNQLGERQLL
     SVVKWSKSLP GFRNLHIDDQ ITLIQYSWMS LMVFGLGWRS YKHVSGQMLY FAPDLILNEQ
     RMKELSFYSL CLTMWQIPQE FVKLQVTHEE FLCMKVLLLL NTIPLEGLRS QSQFEEMRSS
     YIRELIKAIG LRQKGVVPSS QRFYQLTKLL DSLHDLVKQL HLYCLNTFIQ SRTLAVEFPE
     MMSEVIAAQL PKILAGMVKP LLFHKK
//
